362 related articles for article (PubMed ID: 23248097)
1. MUC1 vaccine for individuals with advanced adenoma of the colon: a cancer immunoprevention feasibility study.
Kimura T; McKolanis JR; Dzubinski LA; Islam K; Potter DM; Salazar AM; Schoen RE; Finn OJ
Cancer Prev Res (Phila); 2013 Jan; 6(1):18-26. PubMed ID: 23248097
[TBL] [Abstract][Full Text] [Related]
2. Vaccine against MUC1 antigen expressed in inflammatory bowel disease and cancer lessens colonic inflammation and prevents progression to colitis-associated colon cancer.
Beatty PL; Narayanan S; Gariépy J; Ranganathan S; Finn OJ
Cancer Prev Res (Phila); 2010 Apr; 3(4):438-46. PubMed ID: 20332301
[TBL] [Abstract][Full Text] [Related]
3. Circulating Myeloid Derived Suppressor Cells (MDSC) That Accumulate in Premalignancy Share Phenotypic and Functional Characteristics With MDSC in Cancer.
Ma P; Beatty PL; McKolanis J; Brand R; Schoen RE; Finn OJ
Front Immunol; 2019; 10():1401. PubMed ID: 31275327
[TBL] [Abstract][Full Text] [Related]
4. Novel Vaccine Targeting Colonic Adenoma: a Pre-clinical Model.
Pham T; Carpinteri S; Sampurno S; Pereira L; Roth S; Narasimhan V; Darcy P; Desai J; Heriot AG; Ramsay RG
J Gastrointest Surg; 2019 Mar; 23(3):626-633. PubMed ID: 30623377
[TBL] [Abstract][Full Text] [Related]
5. Preventing cancer by targeting abnormally expressed self-antigens: MUC1 vaccines for prevention of epithelial adenocarcinomas.
Beatty PL; Finn OJ
Ann N Y Acad Sci; 2013 May; 1284():52-6. PubMed ID: 23651193
[TBL] [Abstract][Full Text] [Related]
6. MUC1-specific immune therapy generates a strong anti-tumor response in a MUC1-tolerant colon cancer model.
Mukherjee P; Pathangey LB; Bradley JB; Tinder TL; Basu GD; Akporiaye ET; Gendler SJ
Vaccine; 2007 Feb; 25(9):1607-18. PubMed ID: 17166639
[TBL] [Abstract][Full Text] [Related]
7. Humoral immune response to abnormal MUC1 in subjects with colorectal adenoma and cancer.
Silk AW; Schoen RE; Potter DM; Finn OJ
Mol Immunol; 2009 Nov; 47(1):52-6. PubMed ID: 19217667
[TBL] [Abstract][Full Text] [Related]
8. Strategies for Synthesizing and Enhancing the Immune Response of Cancer Vaccines Based on MUC1 Glycopeptide Antigens.
Yin L; Zhou Y; Hong S; Ding F; Cai H
Chembiochem; 2023 May; 24(10):e202200805. PubMed ID: 36825431
[TBL] [Abstract][Full Text] [Related]
9. ImMucin: a novel therapeutic vaccine with promiscuous MHC binding for the treatment of MUC1-expressing tumors.
Kovjazin R; Volovitz I; Kundel Y; Rosenbaum E; Medalia G; Horn G; Smorodinsky NI; Brenner B; Carmon L
Vaccine; 2011 Jun; 29(29-30):4676-86. PubMed ID: 21570434
[TBL] [Abstract][Full Text] [Related]
10. Vaccination of high-risk breast cancer patients with mucin-1 (MUC1) keyhole limpet hemocyanin conjugate plus QS-21.
Gilewski T; Adluri S; Ragupathi G; Zhang S; Yao TJ; Panageas K; Moynahan M; Houghton A; Norton L; Livingston PO
Clin Cancer Res; 2000 May; 6(5):1693-701. PubMed ID: 10815887
[TBL] [Abstract][Full Text] [Related]
11. Tecemotide: an antigen-specific cancer immunotherapy.
Wurz GT; Kao CJ; Wolf M; DeGregorio MW
Hum Vaccin Immunother; 2014; 10(11):3383-93. PubMed ID: 25483673
[TBL] [Abstract][Full Text] [Related]
12. CancerVax, an allogeneic tumor cell vaccine, induces specific humoral and cellular immune responses in advanced colon cancer.
Habal N; Gupta RK; Bilchik AJ; Yee R; Leopoldo Z; Ye W; Elashoff RM; Morton DL
Ann Surg Oncol; 2001 Jun; 8(5):389-401. PubMed ID: 11407512
[TBL] [Abstract][Full Text] [Related]
13. Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Peptide Vaccine for Prevention of Recurrent Colorectal Adenoma.
Schoen RE; Boardman LA; Cruz-Correa M; Bansal A; Kastenberg D; Hur C; Dzubinski L; Kaufman SF; Rodriguez LM; Richmond E; Umar A; Szabo E; Salazar A; McKolanis J; Beatty P; Pai RK; Singhi AD; Jacqueline CM; Bao R; Diergaarde B; McMurray RP; Strand C; Foster NR; Zahrieh DM; Limburg PJ; Finn OJ
Clin Cancer Res; 2023 May; 29(9):1678-1688. PubMed ID: 36892581
[TBL] [Abstract][Full Text] [Related]
14. Increased immunogenicity of tumor-associated antigen, mucin 1, engineered to express alpha-gal epitopes: a novel approach to immunotherapy in pancreatic cancer.
Deguchi T; Tanemura M; Miyoshi E; Nagano H; Machida T; Ohmura Y; Kobayashi S; Marubashi S; Eguchi H; Takeda Y; Ito T; Mori M; Doki Y; Sawa Y
Cancer Res; 2010 Jul; 70(13):5259-69. PubMed ID: 20530670
[TBL] [Abstract][Full Text] [Related]
15. Reduced Breast Tumor Growth after Immunization with a Tumor-Restricted MUC1 Glycopeptide Conjugated to Tetanus Toxoid.
Stergiou N; Gaidzik N; Heimes AS; Dietzen S; Besenius P; Jäkel J; Brenner W; Schmidt M; Kunz H; Schmitt E
Cancer Immunol Res; 2019 Jan; 7(1):113-122. PubMed ID: 30413430
[TBL] [Abstract][Full Text] [Related]
16. Inflammation-Induced Abnormal Expression of Self-molecules on Epithelial Cells: Targets for Tumor Immunoprevention.
Jacqueline C; Lee A; Frey N; Minden JS; Finn OJ
Cancer Immunol Res; 2020 Aug; 8(8):1027-1038. PubMed ID: 32467324
[TBL] [Abstract][Full Text] [Related]
17. Viral based vaccine TG4010 induces broadening of specific immune response and improves outcome in advanced NSCLC.
Tosch C; Bastien B; Barraud L; Grellier B; Nourtier V; Gantzer M; Limacher JM; Quemeneur E; Bendjama K; Préville X
J Immunother Cancer; 2017 Sep; 5(1):70. PubMed ID: 28923084
[TBL] [Abstract][Full Text] [Related]
18. Enhanced induction of anti-tumor CTLs in vitro by a lentivirus-transduced dendritic cell vaccine expressing secondary lymphoid tissue chemokine and mucin 1.
Wang B; Zhu Y; Zhang JJ; Chen Z; Liang WB; Xu ZK
Asian Pac J Cancer Prev; 2011; 12(11):2811-7. PubMed ID: 22393946
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic vaccine approach for colon and pancreatic cancers: present and future.
Janakiram NB; Mohammed A; Bronze MS; Rao CV
Curr Med Chem; 2012; 19(22):3664-78. PubMed ID: 22680926
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the MUC1.Tg/MIN transgenic mouse as a model for studying antigen-specific immunotherapy of adenomas.
Akporiaye ET; Bradley-Dunlop D; Gendler SJ; Mukherjee P; Madsen CS; Hahn T; Besselsen DG; Dial SM; Cui H; Trevor K
Vaccine; 2007 Sep; 25(39-40):6965-74. PubMed ID: 17707958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
